The European Commission has previously agreed to purchase 300 million doses of a potential coronavirus vaccine, which is being developed by Sanofi-GSK.
This is stated in the official communique of the EC.
The European Commission has completed preliminary negotiations with Sanofi-GSK on the purchase of a potential COVID-19 vaccine.
вЂњThis expected contract with Sanofi-GSK will allow all member countries to purchase the vaccine. It is assumed that as soon as it is proved that the vaccine is safe and effective, the Commission will use the existing basis for a contract for the purchase of 300 million doses of the vaccine, on behalf of all EU member states, вЂњ the report explains.